Source: BEFREE

Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 54093
Gene Symbol: SETD4
SETD4
CUI: C0598766
Disease: Leukemogenesis
Leukemogenesis
0.010 GeneticVariation BEFREE However, in Tp53 deficient mice, Setd4 deletion did not delay the radiation-induced lymphomagenesis although it accelerated the spontaneous T-lymphomagenesis in non-irradiated mice. 31794893

2020

Entrez Id: 974
Gene Symbol: CD79B
CD79B
CUI: C0598766
Disease: Leukemogenesis
Leukemogenesis
0.010 GeneticVariation BEFREE Genetically, PA-DLBCL harbored a high prevalence of MYD88 L265P (24%) and CD79B mutations (52%) which may be involved in lymphomagenesis. 31609782

2020

Entrez Id: 8079
Gene Symbol: MLF2
MLF2
CUI: C0598766
Disease: Leukemogenesis
Leukemogenesis
0.010 PosttranslationalModification BEFREE The role of phosphorylation of MLF2 at serine 24 in BCR-ABL leukemogenesis. 31831854

2020

Entrez Id: 388112
Gene Symbol: NANOGP8
NANOGP8
CUI: C0598766
Disease: Leukemogenesis
Leukemogenesis
0.010 AlteredExpression BEFREE Ultimately, these findings may contribute to understanding the expanded regulatory mechanisms of oncogenic NANOGP8 and ETS family transcription factors in leukemogenesis. 31626853

2020

Entrez Id: 51162
Gene Symbol: EGFL7
EGFL7
CUI: C0598766
Disease: Leukemogenesis
Leukemogenesis
0.010 Biomarker BEFREE Epidermal growth factor-like domain 7 (EGFL7) is a secreted protein and recently has been shown to play an important role in acute myeloid leukemia (AML); however, the underlying mechanism by which EGFL7 promotes leukemogenesis is largely unknown. 31672772

2020

Entrez Id: 116519
Gene Symbol: APOA5
APOA5
CUI: C0598766
Disease: Leukemogenesis
Leukemogenesis
0.010 GeneticVariation BEFREE Furthermore, PCR analysis showed that the chromosome 11 breakpoint was at the APOA5/APOA4 locus at 11q23.3, which is associated with malignancy, and that the chromosome 22 breakpoint was at the SEPT5 intron 1 locus, which also plays a role in leukemogenesis through formation of a fusion gene with MLL. 30680670

2019

Entrez Id: 22807
Gene Symbol: IKZF2
IKZF2
CUI: C0598766
Disease: Leukemogenesis
Leukemogenesis
0.010 Biomarker BEFREE IKZF2 depletion in acute myeloid leukemia (AML) cells reduced colony formation, increased differentiation and apoptosis, and delayed leukemogenesis. 30472158

2019

Entrez Id: 652
Gene Symbol: BMP4
BMP4
CUI: C0598766
Disease: Leukemogenesis
Leukemogenesis
0.010 AlteredExpression BEFREE Due to the important role of the BMM, changes in BMP4 expression through the WNT canonical pathway may be a potential mechanism of leukemogenesis. 30703678

2019

Entrez Id: 100316868
Gene Symbol: HOTTIP
HOTTIP
CUI: C0598766
Disease: Leukemogenesis
Leukemogenesis
0.010 Biomarker BEFREE HOTTIP loss attenuates leukemogenesis of transplanted mice, while reactivation of HOTTIP restores leukemic TADs, transcription, and leukemogenesis in the CTCF-boundary-attenuated AML cells. 31786140

2019

Entrez Id: 6872
Gene Symbol: TAF1
TAF1
CUI: C0598766
Disease: Leukemogenesis
Leukemogenesis
0.010 Biomarker BEFREE Together, our findings reveal a role of TAF1 in leukemogenesis and identify TAF1 as a potential therapeutic target for AE-expressing leukemia. 31664040

2019

Entrez Id: 112597
Gene Symbol: CYTOR
CYTOR
CUI: C0598766
Disease: Leukemogenesis
Leukemogenesis
0.010 Biomarker BEFREE In conclusion, this research reveals the important role of lncRNA LINC00152 in the AML leukemogenesis through targeting miR-193a/CDK9 axis. 30707636

2019

Entrez Id: 5111
Gene Symbol: PCNA
PCNA
CUI: C0598766
Disease: Leukemogenesis
Leukemogenesis
0.010 AlteredExpression BEFREE These results suggest that BCR-ABL induces tyrosine phosphorylation of YAP presumably through Src family kinases, which results in expression of Survivin and Cyclin D leading to leukemogenesis in CML cells. 31428968

2019

Entrez Id: 11141
Gene Symbol: IL1RAPL1
IL1RAPL1
CUI: C0598766
Disease: Leukemogenesis
Leukemogenesis
0.010 Biomarker BEFREE We herein investigated whether concomitant exacerbated inflammation and autoimmunity caused by the deficiency of IL1R8 could recapitulate autoimmunity-associated lymphomagenesis. 31018956

2019

Entrez Id: 23410
Gene Symbol: SIRT3
SIRT3
CUI: C0598766
Disease: Leukemogenesis
Leukemogenesis
0.010 Biomarker BEFREE SIRT3 knockout attenuated B cell lymphomagenesis in VavP-Bcl2 mice without affecting normal GC formation. 31185214

2019

Entrez Id: 284836
Gene Symbol: LINC00319
LINC00319
CUI: C0598766
Disease: Leukemogenesis
Leukemogenesis
0.010 AlteredExpression BEFREE Overall, our findings unveiled that LINC00319 contributed to AML leukemogenesis via elevating SIRT6 expression, indicating a possible molecular target of LINC00319 for AML treatment. 30587342

2019

Entrez Id: 2487
Gene Symbol: FRZB
FRZB
CUI: C0598766
Disease: Leukemogenesis
Leukemogenesis
0.010 Biomarker BEFREE <i>In vivo</i> experiments in NOD scid gamma mice injected with BV173 cells confirmed that FRZB functions as a Wnt/β-catenin inhibitor even as they failed to demonstrate that this pathway is important for BV173-dependent leukemogenesis. 30076175

2019

Entrez Id: 5915
Gene Symbol: RARB
RARB
CUI: C0598766
Disease: Leukemogenesis
Leukemogenesis
0.010 Biomarker BEFREE These uncovered fusion genes strongly suggested their contributions to leukemogenesis as driver alternations and APL phenotype may arise by abnormalities of other members of the nuclear receptor superfamily involved in retinoid signaling (RARB or RARG) or even by mechanisms distinct from the formation of aberrant retinoid receptors. 30575821

2019

Entrez Id: 84295
Gene Symbol: PHF6
PHF6
CUI: C0598766
Disease: Leukemogenesis
Leukemogenesis
0.010 Biomarker BEFREE The functions of PHF6 in physiological hematopoiesis and leukemogenesis remain incompletely defined. 31395598

2019

Entrez Id: 8835
Gene Symbol: SOCS2
SOCS2
CUI: C0598766
Disease: Leukemogenesis
Leukemogenesis
0.010 Biomarker BEFREE SOCS2 promoted leukemogenesis as well as the abundance, quiescence, and activity of AML stem cells. 31235852

2019

Entrez Id: 4684
Gene Symbol: NCAM1
NCAM1
CUI: C0598766
Disease: Leukemogenesis
Leukemogenesis
0.010 Biomarker BEFREE In this study, we investigated the impact of NCAM1 expression on leukemogenesis, drug resistance, and its role as a biomarker to guide therapy. 30814062

2019

Entrez Id: 25766
Gene Symbol: PRPF40B
PRPF40B
CUI: C0598766
Disease: Leukemogenesis
Leukemogenesis
0.010 Biomarker BEFREE Our data suggest a PRPF40B role in repressing hypoxia in myeloid cells, and that its low expression might contribute to leukemogenesis. 31088860

2019

Entrez Id: 64864
Gene Symbol: RFX7
RFX7
CUI: C0598766
Disease: Leukemogenesis
Leukemogenesis
0.010 AlteredExpression BEFREE We also describe a CRISPR/Cas9-based in vivo platform for BCL functional genomics, and validate discovered genes, such as Rfx7, a transcription factor, and Phip, a chromatin regulator, which suppress lymphomagenesis in mice. 30926791

2019

Entrez Id: 5142
Gene Symbol: PDE4B
PDE4B
CUI: C0598766
Disease: Leukemogenesis
Leukemogenesis
0.010 AlteredExpression BEFREE We finally recapitulated this combinatorial effect in Eμ-myc transgenic mice; co-inhibition of Myc and PDE4 suppressed lymphomagenesis and restored B cell development to the wild type level that was associated with marked reduction in Myc levels, unveiling the critical role of the Myc-PDE4B amplification loop in the regulation of Myc expression and the pathogenesis of B cell lymphoma. 31138843

2019

Entrez Id: 2139
Gene Symbol: EYA2
EYA2
CUI: C0598766
Disease: Leukemogenesis
Leukemogenesis
0.010 Biomarker BEFREE These results suggest a critical role of Eya2 in E2A‑HLF‑mediated leukemogenesis. 30628662

2019

Entrez Id: 10413
Gene Symbol: YAP1
YAP1
CUI: C0598766
Disease: Leukemogenesis
Leukemogenesis
0.010 PosttranslationalModification BEFREE These results suggest that BCR-ABL induces tyrosine phosphorylation of YAP presumably through Src family kinases, which results in expression of Survivin and Cyclin D leading to leukemogenesis in CML cells. 31428968

2019